Category

News

TRHC CEO Knowlton Named a Fellow of the College of Physicians of Philadelphia

Moorestown, NJ (June 19, 2017) – Tabula Rasa HealthCare (NASDAQ: TRHC) Chairman and CEO, Calvin H. Knowlton, PhD, was inducted into the College of Physicians of Philadelphia at a gala ceremony, May 19, 2017. CCP is known as the “birthplace of American Medicine.” To become a Fellow means the inductee is “regarded as a learned and dedicated physician, scientist, scholar, practitioner, or provider motivated by the interests of their patients, students, and the public.” Dr.... Read More

TRHC Receives 2017 Enterprise Award from Philadelphia Alliance for Capital and Technologies (PACT)

Moorestown, NJ, May 24, 2017 –Tabula Rasa HealthCare Corporation (NASDAQ: TRHC), a healthcare technology company disrupting the field of medication safety, won its fourth award from the Philadelphia Alliance for Capital and Technologies (PACT) at the 2017 Enterprise Awards held at the Philadelphia Convention Center May 18. TRHC was one of a record 400 companies competing this year for the Annual Enterprise Awards; each category included three finalists. Tabula Rasa won in the category of... Read More

TRHC and Landmark to Improve Patient Outcomes in California and New York

MOORESTOWN, N.J. and HUNTINGTON BEACH, Calif., May 01, 2017 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, has licensed the use of its medication risk mitigation platform, MedWise Advisor®, to Landmark, a leading national medical group focused exclusively on the most chronically ill patients. TRHC Chairman and CEO, Calvin H. Knowlton, PhD, commented, “We look forward to this new partnership with Landmark. This marks the... Read More

Analysis: Reports of drug side effects increase fivefold in 12 years

From the Journal Sentinel More than 1 million reports of drug side effects were filed with the U.S. Food and Drug Administration in 2015, a fivefold increase since 2004, according to an analysis by the Milwaukee Journal Sentinel and MedPage Today. Numbers aren’t final for 2016, but are expected to match that all-time high. Drugs used to treat diseases such as rheumatoid arthritis, psoriasis, multiple sclerosis, a type of cancer and diabetes are among those... Read More

Former Kaiser Permanente Executive Elected to TRHC Board of Directors

Moorestown, NJ (March 10, 2017) – Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a disruptive innovation and technology leader in medication safety, offering a unique Medication Risk Stratification and Medication Risk Mitigation Matrix® suite of decision support tools, elected Dennis K. Helling, PharmD, ScD (Hon), FCCP, FASHP, FAPhA, to its Board of Directors at the firm’s meeting held March 8, 2017. Dr. Helling is the Executive Director Emeritus, Pharmacy Operations & Therapeutics, Kaiser Permanente Colorado, and Clinical... Read More

TRHC Launches Care Transitions Intervention Program for a Large Healthcare Plan

Moorestown, NJ (March 1, 2017) – Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company providing medication safety solutions for health plans and provider groups, has successfully implemented its first payer-based Care Transitions program focused on medication risk mitigation following discharge from a hospital or post-acute care facility. The purpose is to provide comprehensive medication reconciliation and optimization to prevent readmission due to medication problems. According to TRHC Chairman and CEO, Calvin H. Knowlton, PhD,... Read More

Tabula Rasa HealthCare moves its San Francisco-based Operations to a Larger, Technologically-Advanced Facility

Moorestown, N.J., February 20th, 2017 –Tabula Rasa HealthCare (NASDAQ: TRHC), a healthcare technology company providing medication safety solutions for health plans and provider groups, including the Centers for Medicare and Medicaid Services’ (CMS) Program for All-Inclusive Care of the Elderly (PACE), has relocated its California medication decision support center and dispensary. According to TRHC Chairman and CEO Calvin H. Knowlton, PhD, “We were in need of a larger, more technologically-advanced facility that could accommodate our... Read More

JRS IC Coding School Completes First Immersive Class. Graduates Finding Full-time Jobs Following Graduation.

Charleston, SC and Moorestown, NJ (February 17, 2017) – Tabula Rasa HealthCare, Inc.’s (TRHC) JRS (Jack Russell Software) IC (Innovation Center) Coding School completed its first full-time immersive coding class in December 2016. Tom Wilson, Chief Technology Innovation Officer today announced over 60% of graduates received full-time jobs within a month of graduation. “The feedback we have received from hiring managers in the community has been fantastic,” said Wilson. “We know how hard it can... Read More

TRHC Launches Part D Enhanced Medication Therapy Management Program To Improve Medication Use

MOORESTOWN, N.J., Feb. 13, 2017 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company providing medication safety solutions for health plans and provider groups, successfully launched, on January 1, 2017, a pilot program to develop and deliver an Enhanced Medication Therapy Management (i.e., Enhanced MTM) program. The pilot involves seven states included in Medicare Part D Region 25: Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota, and Wyoming. The program addresses the... Read More

TRHC and Mediture Announce Launch of Custom Integration

Tabula Rasa HealthCare and Mediture Announce Launch of Custom Integration to Enhance Workflow and Help Optimize PACE Outcomes Moorestown, NJ –Tabula Rasa HealthCare, Inc.’s (NASDAQ:TRHC) Medication Care Management Division and Mediture, a technology provider of an Electronic Health Record (EHR) used by PACE organizations across the country, announced the official launch of their collaboratively developed custom integration that enables a single electronic record, while accessing TRHC’s proprietary Medication Risk Mitigation Matrix®, at the point of... Read More